43 related articles for article (PubMed ID: 25270516)
1. Association of physical activity and polymorphisms in FGFR2 and DNA methylation related genes with breast cancer risk.
Xi J; Su Y; Beeghly Fadiel A; Lin Y; Su FX; Jia WH; Tang LY; Ren ZF
Cancer Epidemiol; 2014 Dec; 38(6):708-14. PubMed ID: 25270516
[TBL] [Abstract][Full Text] [Related]
2. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.
Agarwal D; Pineda S; Michailidou K; Herranz J; Pita G; Moreno LT; Alonso MR; Dennis J; Wang Q; Bolla MK; Meyer KB; Menéndez-Rodríguez P; Hardisson D; Mendiola M; González-Neira A; Lindblom A; Margolin S; Swerdlow A; Ashworth A; Orr N; Jones M; Matsuo K; Ito H; Iwata H; Kondo N; ; ; Hartman M; Hui M; Lim WY; Iau PT; Sawyer E; Tomlinson I; Kerin M; Miller N; Kang D; Choi J-; Park SK; Noh D-; Hopper JL; Schmidt DF; Makalic E; Southey MC; Teo SH; Yip CH; Sivanandan K; Tay W-; Brauch H; Brüning T; Hamann U; ; Dunning AM; Shah M; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Schmidt MK; Broeks A; Rosenberg EH; van't Veer LJ; Fasching PA; Renner SP; Ekici AB; Beckmann MW; Shen C-; Hsiung C-; Yu J-; Hou M-; Blot W; Cai Q; Wu AH; Tseng C-; Van Den Berg D; Stram DO; Cox A; Brock IW; Reed MW; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Zheng W; Deming-Halverson S; Shrubsole MJ; Long J; Shu X-; Lu W; Gao Y-; Zhang B; Radice P; Peterlongo P; Manoukian S; Mariette F; Sangrajrang S; McKay J; Couch FJ; Toland AE; ; Yannoukakos D; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Marme F; Burwinkel B; Guénel P; Truong T; Sanchez M; Mulot C; Bojesen SE; Nordestgaard BG; Flyer H; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Mannermaa A; Kataja V; Kosma V-; Hartikainen JM; Lambrechts D; Yesilyurt BT; Floris G; Leunen K; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Wang X; Olson JE; Vachon C; Purrington K; Giles GG; Severi G; Baglietto L; Haiman CA; Henderson BE; Schumacher F; Marchand LL; Simard J; Dumont M; Goldberg MS; Labréche F; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Devilee P; Tollenaar RA; Seynaeve C; García-Closas M; Chanock SJ; Lissowska J; Figueroa JD; Czene K; Eriksson M; Humphreys K; Darabi H; Hooning MJ; Kriege M; Collée JM; Tilanus-Linthorst M; Li J; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Bogdanova N; Dörk T; Hall P; Chenevix-Trench G; Easton DF; Pharroah PD; Arias-Perez JI; Zamora P; Benítez J; Milne RL
Br J Cancer; 2014 Feb; 110(4):1088-100. PubMed ID: 24548884
[TBL] [Abstract][Full Text] [Related]
3. FGFR2 genetic variants in women with breast cancer.
Dix-Peek T; Dickens C; Augustine TN; Phakathi BP; Van Den Berg EJ; Joffe M; Ayeni OA; Cubasch H; Nietz S; Mathew CG; Hayat M; Neugut AI; Jacobson JS; Ruff P; Duarte RAB
Mol Med Rep; 2023 Dec; 28(6):. PubMed ID: 37830168
[TBL] [Abstract][Full Text] [Related]
4. Master regulators of FGFR2 signalling and breast cancer risk.
Fletcher MN; Castro MA; Wang X; de Santiago I; O'Reilly M; Chin SF; Rueda OM; Caldas C; Ponder BA; Markowetz F; Meyer KB
Nat Commun; 2013; 4():2464. PubMed ID: 24043118
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in oxidative stress genes, physical activity, and breast cancer risk.
McCullough LE; Santella RM; Cleveland RJ; Bradshaw PT; Millikan RC; North KE; Olshan AF; Eng SM; Ambrosone CB; Ahn J; Steck SE; Teitelbaum SL; Neugut AI; Gammon MD
Cancer Causes Control; 2012 Dec; 23(12):1949-58. PubMed ID: 23053794
[TBL] [Abstract][Full Text] [Related]
6. Association of
Glebauskiene B; Vilkeviciute A; Liutkeviciene R; Jakstiene S; Kriauciuniene L; Zemaitiene R; Zaliuniene D
Oncol Lett; 2017 May; 13(5):3087-3099. PubMed ID: 28521414
[TBL] [Abstract][Full Text] [Related]
7. The Influence of Physical Activity and Epigenomics On Cognitive Function and Brain Health in Breast Cancer.
Wagner MA; Erickson KI; Bender CM; Conley YP
Front Aging Neurosci; 2020; 12():123. PubMed ID: 32457596
[TBL] [Abstract][Full Text] [Related]
8. Exercise: A Path to Wellness During Adjuvant Chemotherapy for Breast Cancer?
Husebø AM; Allan H; Karlsen B; Søreide JA; Bru E
Cancer Nurs; 2015; 38(5):E13-20. PubMed ID: 25275583
[TBL] [Abstract][Full Text] [Related]
9. In utero exposure and breast cancer development: an epigenetic perspective.
Hill J; Hodsdon W
J Environ Pathol Toxicol Oncol; 2014; 33(3):239-45. PubMed ID: 25272062
[TBL] [Abstract][Full Text] [Related]
10. Relationships among folate, alcohol consumption, gene variants in one-carbon metabolism and p16INK4a methylation and expression in healthy breast tissues.
Llanos AA; Dumitrescu RG; Brasky TM; Liu Z; Mason JB; Marian C; Makambi KH; Spear SL; Kallakury BV; Freudenheim JL; Shields PG
Carcinogenesis; 2015 Jan; 36(1):60-7. PubMed ID: 25344837
[TBL] [Abstract][Full Text] [Related]
11. The DAMA trial: a diet and physical activity intervention trial to reduce mammographic breast density in postmenopausal women in Tuscany, Italy. Study protocol and baseline characteristics.
Masala G; Assedi M; Caini S; Ermini I; Occhini D; Castaldo M; Bendinelli B; Zagni D; Tanzini D; Saieva C; Ambrogetti D; Palli D
Tumori; 2014; 100(4):377-85. PubMed ID: 25296586
[TBL] [Abstract][Full Text] [Related]
12. Association of rs1219648 in FGFR2 and rs1042522 in TP53 with premenopausal breast cancer in an Iranian Azeri population.
Saadatian Z; Gharesouran J; Ghojazadeh M; Ghohari-Lasaki S; Tarkesh-Esfahani N; Mohaddes Ardebili SM
Asian Pac J Cancer Prev; 2014; 15(18):7955-8. PubMed ID: 25292094
[TBL] [Abstract][Full Text] [Related]
13. The shared mother-child epigenetic signature of neglect is related to maternal adverse events.
León I; Herrero Roldán S; Rodrigo MJ; López Rodríguez M; Fisher J; Mitchell C; Lage-Castellanos A
Front Physiol; 2022; 13():966740. PubMed ID: 36091392
[TBL] [Abstract][Full Text] [Related]
14. Correlation of FGFR2 rs2981582 polymorphisms with susceptibility to breast cancer: a case-control study in a Chinese population.
Shu J; Hui X; Zheng X; Zhao J; Xu Z; Chen Y; Lu C; Li J
J Int Med Res; 2019 Oct; 47(10):4753-4763. PubMed ID: 31448667
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast Growth Factor Receptor 2 Signaling in Breast Cancer.
Lei H; Deng CX
Int J Biol Sci; 2017; 13(9):1163-1171. PubMed ID: 29104507
[TBL] [Abstract][Full Text] [Related]
16. The correlations between DNA methylation and polymorphisms in the promoter region of the human telomerase reverse transcriptase (hTERT) gene with postoperative recurrence in patients with thyroid carcinoma (TC).
Li JJ; Zheng PCJ; Wang YZ
World J Surg Oncol; 2017 Jun; 15(1):114. PubMed ID: 28587656
[TBL] [Abstract][Full Text] [Related]
17. A Meta-Analysis of the Association between
Li H; Liu JW; Sun LP; Yuan Y
Biomed Res Int; 2017; 2017():3971259. PubMed ID: 28473984
[TBL] [Abstract][Full Text] [Related]
18. Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis.
Zhang Y; Zeng X; Liu P; Hong R; Lu H; Ji H; Lu L; Li Y
Oncotarget; 2017 Jan; 8(2):3454-3470. PubMed ID: 27966449
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.
Lv H; Zhang M; Shang Z; Li J; Zhang S; Lian D; Zhang R
Oncotarget; 2017 Jan; 8(5):7891-7899. PubMed ID: 27903959
[TBL] [Abstract][Full Text] [Related]
20. The association between methylenetetrahydrofolate reductase gene C677T polymorphisms and breast cancer risk in Chinese population.
Wang Y; Yang H; Gao H; Wang H
Tumour Biol; 2015 Dec; 36(12):9153-8. PubMed ID: 26537580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
